Nisoldipine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nisoldipine. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Peripheral | 29% |
| Peripheral edema | 22% |
| Headache | 22% |
| Dizziness | 5% |
| Pharyngitis | 5% |
| Vasodilation | 4% |
| Sinusitis | 3% |
| Palpitation | 3% |
| Chest pain | 2% |
| Nausea | 2% |
| Rash | 2% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Nisoldipine extended-release tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.
Source: FDA labeling via NIH DailyMed (set bab6e4c1…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.